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Abstract: Polyunsaturated fatty acids (PUFAs) are essential for fetal development, and intrauterine
transfer is the only supply of PUFAs to the fetus. The prevailing theory of gestational nutrient
transfer is that certain nutrients (including PUFAs) may have prioritized transport across the
placenta. Numerous studies have identified correlations between maternal and infant fatty acid
concentrations; however, little is known about what role maternal PUFA status may play in
differential intrauterine nutrient transfer. Twenty mother–infant dyads were enrolled at delivery
for collection of maternal and umbilical cord blood, and placental tissue samples. Plasma
concentrations of PUFAs were assessed using gas chromatography (GC‐FID). Intrauterine transfer
percentages for each fatty acid were calculated as follows: ((cord blood fatty acid level/maternal
blood fatty acid level) x 100). Kruskal–Wallis tests were used to compare transfer percentages
between maternal fatty acid tertile groups. A p‐value < 0.05 was considered significant. There were
statistically significant differences in intrauterine transfer percentages of arachidonic acid (AA)
(64% vs. 65% vs. 45%, p = 0.02), eicosapentaenoic acid (EPA) (41% vs. 19% vs. 17%, p = 0.03), and
total fatty acids (TFA) (27% vs. 26% vs. 20%, p = 0.05) between maternal plasma fatty acid tertiles.
Intrauterine transfer percentages of AA, EPA, and TFA were highest in the lowest tertile of
respective maternal fatty acid concentration. These findings may indicate that fatty acid transfer to
the fetus is prioritized during gestation even during periods of maternal nutritional inadequacy.
Keywords: omega‐3 fatty acids; PUFA; intrauterine transfer; maternal‐fetal health; placenta
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1. Introduction
Polyunsaturated fatty acids (PUFAs) are essential for growth and development
during pregnancy, particularly structural growth in the third trimester such as cell
membranes, the retina, and the brain. During the perinatal period, PUFAs also aid in the
development of a functional immune system by altering the function of regulatory T cells,
the growth of fetal neural cells, and signal transduction [1]. While in utero, fetuses rely
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on transfer of PUFAs through the placenta and umbilical cord; some studies have shown
that maternal dietary intake of PUFAs can impact umbilical cord concentrations [1,2].
Although PUFAs have been extensively studied in pregnancy, the dynamics of
intrauterine nutrient transfer across the placenta are still not well understood. Transfer of
nutrients across the placenta is the single source of nutrition for a growing fetus and, as
such, transfer of these nutrients is critical for appropriate fetal development. Compounds
that cross the placenta efficiently are small, uncharged molecules, such as oxygen, which
depend on rate of blood flow to be able to cross the placenta [3]. Larger charged molecules
are often able to cross the placenta with the aid of intraplacental transporters, as is the case
with glucose crossing the placenta via glucose transporters (GLUT) proteins [3,4]. PUFAs
including linoleic acid (LA), α‐linolenic acid (ALA), arachidonic acid (AA),
docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), and eicosapentaenoic acid
(EPA) are large molecules and do not readily cross the placenta; placental transport of
fatty acids is heavily transporter dependent, and the mechanisms that regulate
preferential transfer remain poorly understood [5]. Among nutrients that are highly
transferred, such as glucose, there does not seem to be a consistent correlation between
maternal plasma level and fetal growth [6]. However, micronutrients that may be subject
to tighter regulation have shown correlation to fetal growth such as retinol, which is
essential during pregnancy to support fetal growth [7]. Placental PUFA transfer appears
to rely largely on plasma membrane bound proteins that bind non‐esterified fatty acids
and transport them across the membrane, with a small number of fatty acids being able
to cross the placental membrane via passive diffusion [8]. Since the maternal to fetal
gradient of free fatty acids is high, some passive diffusion can occur; however, these fatty
acids are processed and esterified prior to release into the fetal circulation [9].
Throughout the course of pregnancy, maternal plasma PUFA concentrations
decrease with ultimately higher concentrations of fatty acids in cord blood at delivery
than in maternal plasma [10]. For example, increased concentrations of DHA have been
found in cord blood compared to maternal plasma concentration, indicating there may be
some selectivity for specific fatty acids to more easily transfer across the placenta [4]. In
some studies, placental concentrations of DHA and AA have been shown to be up to 4‐
fold higher in the placental intervillous space than in the maternal plasma, indicating an
increase in the transfer of these specific fatty acids [11]. Some studies have been conducted
to investigate the mechanics of intrauterine PUFA transfer using radio‐labelled fatty acid
supplements [12], and others have evaluated direct correlations between maternal and
fetal fatty acid levels [13–16]; however, minimal investigation has been conducted on
differential intrauterine PUFA transfer in the context of varied maternal nutrient status.
Therefore, the purpose of this study is to quantify the intrauterine transfer percentages of
six PUFAs between maternal plasma fatty acid tertile groups.
2. Materials and Methods
2.1. Subjects
An Institutional Review Board‐approved (#112‐15‐EP, 4/14/15) study at the
University of Nebraska Medical Center (Omaha, NE, USA) screened and enrolled twenty
mother–infant dyads at the time of delivery. Informed written consent was acquired from
the mother (for herself and her infant) prior to study participation. Inclusion criteria
included mothers ≥ 19 years of age and delivering at least one live‐born infant at term
gestational age (≥37 weeks gestation [17]), and exclusion criteria included congenital
abnormalities, inborn errors of metabolism, other conditions that may impact the
metabolism of fatty acids, and infants deemed wards of the state.
Only mother–infant pairs with both maternal and umbilical cord plasma results were
included in this analysis.

Nutrients 2021, 13, 996

3 of 11

2.2. Sample Collection
Maternal blood, umbilical cord blood, and placental tissue cross‐sections were
collected from participants at time of delivery by study personnel, and promptly
processed and stored at −80 °C. Target volume for plasma samples was 150 μL of plasma,
and placental cross sections had a target volume of 1 g. All samples were protected from
heat and light to minimize degradation of unstable molecules.
2.3. Fatty Acid Analysis
Plasma fatty acid composition was analyzed by gas chromatography with flame
ionization detection (GC‐FID) at OmegaQuant Analytics LLC (Sioux Falls, SD, USA).
Plasma was transferred to a screw‐cap glass vial and boron trifluoride‐methanol (BTM)
solution (methanol containing 14% boron trifluoride, toluene, methanol; 35:30:35 v/v/v;
Sigma‐Aldrich, St. Louis, MO, USA) was added. The vial was briefly vortexed and heated
in a hot bath at 100 °C for 45 min. After cooling, hexane (Merck KGaA, Darmstadt,
Germany) and high‐performance liquid chromatography grade water was added. The
tubes were recapped, vortexed, and centrifuged to separate layers. An aliquot of the
hexane layer was transferred to a GC vial. GC was carried out using a GC‐2010 Gas
Chromatograph (Shimadzu Corporation, Columbia, MD, USA) equipped with a SP‐2560,
100 m fused silica capillary column (0.25 mm internal diameter, 0.2 um film thickness;
Supelco, Bellefonte, PA, USA).
Fatty acids were identified by comparison with a standard mixture of fatty acids
(GLC OQ‐A, NuCheck Prep, Elysian, MN, USA) which was also used to determine
individual fatty acid calibration curves. PUFAs of interest include linoleic acid (LA), α‐
linolenic acid (ALA), arachidonic acid (AA), docosapentaenoic acid (DPA),
docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and Total Fatty Acids (TFA).
2.4. Clinical and Demographic Data
Demographic variables included infant sex and maternal race. Clinical data included
delivery mode (vaginal vs. caesarean), birth weight in grams, gestational age in weeks,
birth length in centimeters, and birth head circumference in centimeters. We additionally
collected maternal pre‐pregnancy body mass index (BMI). All data were collected from
the electronic medical record at the time of delivery. Maternal dietary intake was
quantified by completing the Willet Food Frequency Questionnaire, a quantitative survey
that calculates daily nutrient intake based on reported diet over the last year, and is
validated in multiple populations including pregnant women [18].
2.5. Statistical Analysis
Descriptive statistics were calculated for all variables, including median and
interquartile ranges (IQR) for continuous variables and counts and proportions are
presented for categorical variables. Intrauterine transfer percentage for each PUFA was
calculated as ((umbilical cord blood fatty acid level/maternal blood fatty acid level) x 100).
The Kruskal–Wallis test and post‐hoc tests were used to compare intrauterine transfer
percentages between maternal fatty acid tertiles. IBM SPSS Statistics 25 software (IBM
Corp., New York, NY, USA) was used for statistical analyses. A p‐value < 0.05 was
considered statistically significant.
3. Results
There were 20 mother–infant dyads included in this study. Demographic data for
participants are displayed in Table 1.
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Table 1. Demographic Data of Mother–Infant Dyads.

Infant CGA (weeks)
Infant birthweight (g)
Infant birth length (cm)
Infant birth head circumference (cm)
Maternal pre‐pregnancy BMI (kg/m2)
Infant sex:
Male
Female
Maternal race:
White
Black/African American
Hispanic/Latino
Asian/Pacific Islander
Native American/Alaskan
Other/Unknown
Delivery mode:
Vaginal
Caesarean

Median
39.45
3467
50.50
34.60
24.7
Count (n)

IQR
39.0–40.2
3172.5–3758.0
48.3–50.8
33.0–35.6
21.2–28.9
Percentage (%)

11
9

55.0
45.0

10
4
3
1
0
2

50.0
20.0
15.0
5.0
0.0
10.0

18
2

90.0
10.0

Min
37.4
2955
45.7
32.4
18.2

Max
41.0
4893
53.3
36.8
43.9

CGA = Corrected Gestational Age, BMI = Body‐Mass Index

The raw concentrations of each measured PUFA in maternal plasma, umbilical cord,
and placenta, which were used to calculate transfer percentage, can be found in Tables 2–
4, respectively. The maternal dietary intake as determined by Willet Food Frequency
Questionnaire for each nutrient is provided in Table 5.
Table 2. Concentrations of PUFAs in Maternal Plasma.
Linoleic Acid (μg/mL)
α‐Linolenic Acid (μg/mL)
Arachidonic Acid (μg/mL)
Eicosapentaenoic Acid (μg/mL)
Docosapentaenoic‐n3 Acid
(μg/mL)
Docosahexaenoic Acid (μg/mL)
Total Fatty Acids (μg/mL)

Median
IQR
33rd %ile 67th %ile
1482.6 1322.0–1618.9 1342.4
1584.5
35.6
28.5–39.4
33.8
39.4
272.7
202.8–312.6
224.21
289.2
6.0
4.0–9.3
5.0
7.2
10.1

9.0–12.0

9.2

12.0

72.7
4794.0

59.4–81.7
4062.2–5208.2

62.4
4601.1

80.4
5093.7

Min
973.9
24.2
183.5
2.0

Max
2122.3
52.5
417.6
18.5

7.0

20.8

37.6
161.3
3423.8 7138.1

%ile = percentile

Table 3. Concentrations of PUFAs in Umbilical Cord Plasma.

Linoleic Acid (μg/mL)
α‐Linolenic Acid (μg/mL)
Arachidonic Acid (μg/mL)
Eicosapentaenoic Acid (μg/mL)
Docosapentaenoic‐n3 Acid (μg/mL)
Docosahexaenoic Acid (μg/mL)
Total Fatty Acids (μg/mL)
IQR = Interquartile Range

Median
136.8
2.5
162.6
1.2
2.4
36.7
1155.5

IQR
101.0–184.7
1.2–3.1
125.8–181.7
0.9–2.5
1.7–3.5
30.1–46.5
964.5–1341.8

Min
89.6
0.7
89.4
0.7
0.7
19.2
721.2

Max
1342.6
40.0
251.6
8.4
10.0
83.3
4621.2
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Table 4. Concentrations of PUFAs in Placenta.

Linoleic Acid (μg/mg)
α‐Linolenic Acid (μg/mg)
Arachidonic Acid (μg/mg)
Eicosapentaenoic Acid (μg/mg)
Docosapentaenoic‐n3 Acid (μg/mg)
Docosahexaenoic Acid (μg/mg)
Total Fatty Acids (μg/mg)

Median
1.11
0.01
2.09
0.01
0.07
0.32
9.97

IQR
1.0–1.3
0.009–0.012
1.8–2.3
0.005–0.010
0.05–0.08
0.26–0.44
8.63–10.72

Min
0.72
0.01
1.28
0.00
0.03
0.18
6.82

Max
1.56
0.02
2.51
0.02
0.12
0.64
12.46

IQR = Interquartile Range

Table 5. Maternal PUFA Dietary Intake.

Median
9.42
1.19
0.12
0.01
0.02
0.06
1.33

Linoleic Acid (g)
α‐Linolenic Acid (g)
Arachidonic Acid (g)
Eicosapentaenoic Acid (g)
Docosapentaenoic‐n3 Acid (g)
Docosahexaenoic Acid (g)
Total Omega‐3 Acid (g)

IQR
8.2–14.2
0.9–1.4
0.1–0.2
0–0.05
0.01–0.02
0.03–0.12
0.9–1.6

Min
1.8
0.2
0.0
0.0
0.0
0.0
0.22

Max
18.7
1.9
0.3
0.4
0.1
0.4
2.01

IQR = Interquartile Range

There was a statistically significant difference in intrauterine transfer percentages of
AA, EPA, and TFA between maternal fatty acid tertiles (Table 6). Transfer percentages of
AA, EPA, and TFA were highest in mothers in the lowest tertile of respective fatty acid
concentration. For EPA, mothers in the middle and highest tertiles transferred 19.3% and
17.6%, respectively, whereas mothers in the lowest tertile of plasma concentration
transferred 41.1% (p = 0.03). For AA, mothers in the highest tertile of maternal plasma level
transferred 45.2%, while mothers in the middle and lowest tertiles transferred 65.8% and
64.8%, respectively (p = 0.02). The TFA transfer pattern is similar to AA; TFA in mothers
with the highest tertile of maternal plasma level transferred 19.6%, while mothers in the
middle and lowest tertiles transferred 25.7% and 26.9%, respectively (p‐value = 0.05).
Table 6. Kruskal–Wallis Test of Intrauterine Transfer Percentage by Maternal Plasma Level Tertile.

n
Linoleic Acid
α‐linolenic Acid
Arachidonic Acid
Docosapentaenoic Acid
Docosahexaenoic Acid
Eicosapentaenoic Acid
Total Fatty Acids

20
20
20
20
20
20
20

Tertile 3
Tertile 1
Tertile 2
(Highest)
(Lowest)
10.3%
9.2%
9.8%
4.8%
7.0%
6.8%
64.8%
65.8%
45.2%
31.0%
20.3%
20.1%
57.8%
52.4%
45.9%
41.1%
19.3%
17.7%
26.9%
25.7%
19.6%

p‐Value
0.86
0.68
0.02 *
0.68
0.60
0.03 *
0.05 *

* indicates p‐value ≤ 0.05

Pairwise comparisons for each nutrient are presented in Figures 1–3. These data
exhibit a statistically significantly difference for mothers of the highest tertile of AA
concentration versus mothers of the middle and lowest tertile of AA concentration (Figure
1). There was also a statistically significant difference in the transfer of EPA in mothers in
lowest tertile and the transfer of EPA in mothers in the two highest tertiles (Figure 2).
There was again a statistically significant difference between transfer of TFA in mothers
of the lowest tertile and mothers of the two highest tertiles (Figure 3). This difference in
intrauterine transfer by maternal fatty acid tertile was not seen in DPA, DHA, LA, or ALA.
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Figure 1. Median transfer percentage of arachidonic acid (AA) across tertiles of maternal plasma
AA concentration.

Figure 2. Intrauterine transfer percentage of eicosapentaenoic acid (EPA) across tertiles of
maternal plasma concentration.
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Figure 3. Intrauterine transfer percentage of total fatty acid across tertiles of maternal plasma
concentration. Asterisk refers to Tertile 2.

4. Discussion
The findings of this study may indicate that there may be a prioritization of
intrauterine transfer of some, but not all, fatty acids to the fetus, particularly in the setting
of low maternal nutrient status [11]. We have earlier surveyed the amount of fatty acid
intake among multiple population groups, including pregnant women, from 2003 to 2014
using the National Health and Nutrition Examination Survey database and found that
pregnant women are well below the recommended dietary intake levels of omega‐3 fatty
acid intakes [19]. Recommended daily allowance of omega‐3 fatty acid dietary intake in
pregnant women varies widely, with some organizations recommending up to 650
mg/day with at least 220 mg/day of each DHA and EPA [20]. Failure to achieve these levels
could result in latent consequences to the fetus, as PUFAs are not only important for
intrauterine development of the retina and brain [4] but also for postnatal visual function
and neurodevelopment [21]. The nutritional environment during early pregnancy may
even affect fetal gene expression, particularly in the case of PUFA deficiency where there
may not be enough PUFAs to reduce inflammation [22]. In this study, we saw that median
total omega‐3 fatty acid intake reached recommended intake levels for pregnant women,
with their average total dietary intake of omega‐3 fatty acids 1330 mg, but median intake
of DHA was only 60 mg and median intake of EPA was just 10 mg (Table 5). Interestingly,
in mothers with the lowest levels of plasma EPA, we identified the highest intrauterine
transfer percentages of EPA. These data suggest that certain fatty acids essential to
pregnancy may be selectively transferred to the infant, regardless of maternal nutrition
status. However, DHA and DPA did not exhibit differential transfer percentages amongst
different maternal plasma PUFA tertiles, suggesting that infants could be at risk for lower
PUFA status in one of these important omega‐3 fatty acids in mothers having lower DHA
and DPA intakes or plasma levels. Of note, a previous study evaluating the mechanics of
intrauterine fatty acid transfer using radiolabeled fatty acid supplements indicated a
significantly higher accretion of DHA in the placental tissue compared to palmitic acid,
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oleic acid, and linoleic acid [12]—this adds important context to our findings, in that DHA
may not have variable transfer from maternal blood to cord blood based on maternal DHA
status due to its high uptake in the interposed placental tissue. Taken in conjunction with
previous studies indicating poor intake of PUFAs in pregnant women in the United States
[19], our results highlight that some, but not all, fatty acids may have increased
intrauterine transfer when maternal stores are low. These data may indicate the
importance of targeted nutrient supplementation and strategic diet modifications to
optimize nutrient availability in women of childbearing age.
These results, which show a potentially increased transfer of AA, may be counter‐
intuitive given AA’s reputation as a substrate for the production of many pro‐
inflammatory mediators. However, AA is a PUFA which is essential for many normal
human functions, particularly in the nervous system [23]. Additionally, while AA
contributes to Type II immune responses, its oxidative metabolites such as downstream
P450 metabolites including epoxyeicosatrienoic acids, contribute to the resolution of
inflammation [23,24]. Given the prolonged period of development, intrauterine
augmentation of AA transfer to the fetus may be beneficial to support critical neonatal
development [25,26]. Since AA has a proven benefit to nervous system function,
augmentation of intrauterine transfer may be necessary given the longevity and cruciality
of fetal nervous system development throughout pregnancy. In contrast to AA, other
PUFAs that did not appear to have increased transfer percentages are also essential for
fetal development. LA and ALA are considered essential fatty acids that must be obtained
from the diet, since they contain molecularly structured bonds that cannot be synthesized
by the body [27]. LA and ALA are the building blocks of AA, EPA, DHA. It has been
hypothesized that the concentration of AA, EPA, and DHA are markers of placental
function [11]. Thus, our findings of increased AA and EPA may point towards the optimal
function of the placenta in these healthy pregnancies in terms of metabolism of ALA and
LA.
The amount of available free fatty acids for a fetus may have a positive impact on
appropriate fetal development. Previous studies have evaluated fatty acid correlations
between maternal and infant blood, as well as their relationship with infant outcomes. For
instance, Meher et al. [13] assessed differences in maternal and cord fatty acid levels
between low birthweight infants and appropriate for gestational age infants, as well as
the correlations between maternal and infant erythrocyte fatty acid concentrations [13].
This study observed direct correlations between maternal and cord DHA, AA, and TFA
at multiple timepoints during pregnancy. However, our study aims to assess the
intrauterine transfer of fatty in the context of disparate maternal nutrient status. Other
studies have discussed the dynamics of biomagnification in the context of PUFAs [14,28],
and the potential for prioritized nutrient transfer regardless of low available maternal
substrate. Another potential implication of increased PUFA substrate is the anti‐
inflammatory properties of PUFAs, especially omega‐3 fatty acids [29]. Increased PUFA
transfer across the placenta over the course of pregnancy has been hypothesized to
prepare a fetus for the oxidative stresses of extrauterine life [29]. The downstream
metabolites of omega‐3 fatty acids have been shown to promote the resolution of
inflammatory cascades [30]. Since intrauterine transfer of certain fatty acids seems to be
prioritized, it may be possible that this is due to the increased need for anti‐inflammatory
substrate, particularly in the first few months of life as infants are susceptible to infection
prior to the full development of an infantile immune system [31,32]. The results of this
study suggest a fetal requirement for a minimal concentration of PUFAs which may
potentially have positive implications for fetal development, inflammation resolution,
and improved neurodevelopmental outcomes.
Strengths and Limitations
This study population included mother–infant dyads of term pregnancies, which
limits the confounding role that placental abnormality, morbidities of prematurity, and
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differences in placental development may have on intrauterine nutrient transfer.
However, a very small sample size limits our ability to make strong claims that these
results are generalizable to a broader population, as well as adjusting our findings for
potential confounding effects. Specifically, the significant difference in TFA transfer
percentage may be the product of the significantly different transfer percentages of two
constituent parts (AA and EPA). However, we were unable to assess this possibility
statistically given our small sample size. Further analyses of PUFA intrauterine transfer
percentages in a larger cohort of mother–infant dyads will be necessary to determine the
validity and reproducibility of the results presented in this manuscript. An additional
limitation of this study is that our study evaluated fatty acid levels in maternal and infant
plasma rather than erythrocyte composition. There is some discussion about which
methodology is most appropriate to assess nutrient status, particularly over longer
periods of time [33]. In future studies, we plan to evaluate fatty acid plasma concentration
and erythrocyte composition in parallel to address this potential limitation. Finally, the
possibility of a selection bias in that all subjects of this study were pregnancies that were
carried to full‐term. This selection bias could discount the possibility that fetuses who
reached full term as those who are able to receive enough fatty acid via intrauterine
transfer and potentially mothers of lower nutritional status are more likely to have
preterm infants and were thus not included in this study. Nonetheless, we report data
answering to an important question of differential fatty acid transfer in the setting of
pregnancy, with indications that fetal nutrient delivery of certain fatty acids is prioritized
even in deplete settings.
5. Conclusions
Our data in the present study indicate that intrauterine transfer of AA, EPA, and TFA
is higher in mothers in the lowest tertiles of their respective plasma fatty acid
concentrations. This difference was not seen in the transfer of DPA, DHA, LA, or ALA.
These results imply that there is a minimum transfer percentage of specific nutrients
required for appropriate fetal development, regardless of maternal nutrition status. Given
the importance of PUFAs in fetal development, these results may further support the
importance of achieving the recommended dietary levels of PUFAs in pregnant women
and also targeting specific maternal PUFA deficiencies via supplementation in cases
where intrauterine transfer percentages do not differ significantly based on maternal
serum levels (e.g., DHA and DPA).
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